Sunday, February 28, 2021 12:31:19 PM
Outstanding Share count increased from 265,299 to 104,265,299. So the increase of 104,000,000 shares are made up of 104,100,093 RESTRICTED SHARES. Still only leaves 165,206 unrestricted shares to be traded.
As of October 31, 2020:
Trading symbol: XLTD
Exact title and class of securities outstanding – Common Stock
CUSIP: 3015J102
Par or stated value: $0.001
Total shares authorized: 500,000,000 as of date: October 31, 2020
Total shares outstanding: 265,299 as of date: October 31, 2020
Number of shares in the public float: 104,249 as of date: October 31, 2020
Total number of shareholders of record: 253 as of date: October 31, 2020
https://sec.report/otc/financial-report/267222/Annual-Report-For-the-Period-Ending-October-31-2020.pdf
$XLTD current Share Structure as of 2/26/21
Market Cap Market Cap 1,042,652,990 02/26/2021
Authorized Shares 500,000,000 02/26/2021
Outstanding Shares 104,265,299 02/26/2021
Restricted 104,100,093 02/26/2021
Unrestricted 165,206 02/26/2021
Held at DTC 115,551 02/26/2021
Recent HNOI News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:41:46 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/26/2024 05:15:10 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/05/2024 09:24:01 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/29/2024 08:54:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 06:09:19 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/08/2024 06:41:41 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/19/2023 07:59:18 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/27/2023 04:58:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 06:19:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/14/2023 08:16:41 PM
- Form 8-A12G - Registration of securities [Section 12(g)] • Edgar (US Regulatory) • 07/11/2023 07:04:59 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM